Literature DB >> 35509747

Gastric Perforation as a Complication of COVID-19 Infection: A Case Report.

Abdulrahman S Almulhim1, Alaa Alghazzi2, Ali A Almohammed Saleh3, Ahmed H Alsulaiman3, Lojain A Alnosair4, Fatimah Y Alghareeb5.   

Abstract

Pulmonary symptoms are the primary manifestation of the COVID-19 disease, which originated in Wuhan in China in December 2019. However, it is now established to show widespread extrapulmonary manifestations, including gastrointestinal involvement. Abdominal pain, diarrhea, nausea, and vomiting are considered the most common gastrointestinal symptoms. Gastric perforation in association with COVID-19 is rarely reported in the literature. Here, we report a case of a 71-year-old male COVID-19-infected patient, medically free, who presented to the emergency department complaining of severe abdominal pain for a one-week duration. He was diagnosed with a case of perforated viscus and septic shock. The patient was shifted to the operating room for exploratory laparotomy. We aim in this report to highlight this fatal complication of COVID-19 infection in order to improve patients' outcomes.
Copyright © 2022, Almulhim et al.

Entities:  

Keywords:  covid 19; gastrointestinal perforation; medical icu; multi-organ dysfunction; sars-cov 2 infection

Year:  2022        PMID: 35509747      PMCID: PMC9060744          DOI: 10.7759/cureus.23725

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  28 in total

1.  Complications of Biliopancreatic Diversion Surgery as Proposed by Scopinaro in the Treatment of Morbid Obesity.

Authors: 
Journal:  Obes Surg       Date:  1996-10       Impact factor: 4.129

Review 2.  Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel.

Authors:  L Aabakken; M Osnes
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 3.  Covid-19 and the digestive system.

Authors:  Sunny H Wong; Rashid Ns Lui; Joseph Jy Sung
Journal:  J Gastroenterol Hepatol       Date:  2020-04-19       Impact factor: 4.029

4.  COVID-19 gastrointestinal symptoms mimicking surgical presentations.

Authors:  J Ashcroft; V E Hudson; R J Davies
Journal:  Ann Med Surg (Lond)       Date:  2020-06-24

5.  Gastrointestinal perforation in a critically ill patient with COVID-19 pneumonia.

Authors:  Aaron Kangas-Dick; Christopher Prien; Kristin Rojas; Qinghua Pu; Mohammad Hamshow; Elias Wan; Kabu Chawla; Ory Wiesel
Journal:  SAGE Open Med Case Rep       Date:  2020-07-16

6.  A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias.

Authors:  Dahai Zhao; Feifei Yao; Lijie Wang; Ling Zheng; Yongjun Gao; Jun Ye; Feng Guo; Hui Zhao; Rongbao Gao
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

7.  Perforated Marginal Ulcer in a COVID-19 Patient. Laparoscopy in these Trying Times?

Authors:  A Galvez; K King; M El Chaar; L Claros
Journal:  Obes Surg       Date:  2020-11       Impact factor: 4.129

8.  The impact of early surgical intervention in free intestinal perforation: a time-to-intervention pilot study.

Authors:  Andreas Hecker; E Schneck; R Röhrig; F Roller; B Hecker; J Holler; C Koch; M Hecker; M Reichert; C Lichtenstern; G A Krombach; W Padberg; M A Weigand
Journal:  World J Emerg Surg       Date:  2015-11-06       Impact factor: 5.469

9.  Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.

Authors:  Lu Lin; Xiayang Jiang; Zhenling Zhang; Siwen Huang; Zhenyi Zhang; Zhaoxiong Fang; Zhiqiang Gu; Liangqing Gao; Honggang Shi; Lei Mai; Yuan Liu; Xianqi Lin; Renxu Lai; Zhixiang Yan; Xiaofeng Li; Hong Shan
Journal:  Gut       Date:  2020-04-02       Impact factor: 23.059

10.  Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.

Authors:  Lei Pan; Mi Mu; Pengcheng Yang; Yu Sun; Runsheng Wang; Junhong Yan; Pibao Li; Baoguang Hu; Jing Wang; Chao Hu; Yuan Jin; Xun Niu; Rongyu Ping; Yingzhen Du; Tianzhi Li; Guogang Xu; Qinyong Hu; Lei Tu
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.